Sílvia Pires Lourenço
Silvia Pires Lourenço received her Bachelor in Molecular Cell Biology from Faculty of Science and Technology, New University of Lisbon, in Portugal. She then proceeded to finish a 2 years Master in Molecular Biology and Genetics from the Faculty of Sciences, University of Lisbon, Portugal. In 2013 she joined the Graduate Program in the areas of Basic and Applied Biology at University of Porto, Portugal. She joined the Rivella lab as a graduate student in 2014. Her projects focused on developing two pronged approaches using lentiviral vector for the cure of beta-globinopathies.